Liver immunotoxicity showed a trend towards reduced cancer progression, although this did not achieve statistical significance (9 patients (52.9%) with immunotoxicity vs. 390 (86.1%) without; HR 0.51; 95% CI 0.23–1.16; p = 0.08).
← all excerpts
Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy.
1
—
—